title: Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.
abstract: The effects of taurine on hepatic cholesterol metabolism were investigated in hamsters fed a high-fat diet or normal chow. Two weeks-treatment of taurine at 1% in drinking water prevented high-fat diet-induced increase in cholesterol levels of serum and liver. The decrease in serum cholesterol by taurine was due to decrease in non-HDL cholesterols. A similar tendency was noted in serum and liver cholesterol levels of hamsters fed a normal diet. In hamsters fed a high-fat diet, taurine prevented elevation in hepatic activity of acyl-CoA:cholesterol acyltransferase (ACAT) and increased the activity of cholesterol 7alpha-hydroxylase. Taurine also increased cholesterol 7alpha-hydroxylase activity in hamsters fed normal chow. Studies on liver membranes revealed that taurine increased 125I-labeled LDL binding by 52% and 58% in hamsters fed either a normal chow or high-fat diet, respectively. Furthermore, LDL kinetic analysis showed that taurine intake resulted in significant faster plasma LDL fractional catabolic rates (FCR). These results suggest that taurine elevates hepatic LDL receptor and thereby decreases serum cholesterol levels, an event which may be the result of hepatic cholesterol depletion as a consequence of increased bile acid synthesis via enhancement of cholesterol 7alpha-hydroxylase activity. Thus, up-regulation of the LDL receptor and subsequent increase in receptor- mediated LDL turnover may be a key event in the cholesterol-lowering effects of taurine in hamsters.
authors.affiliation: Medicinal Research Laboratories, Taisho Pharmaceutical Co, Ltd, Saitama, Japan. shigeru.murakami@po.rd.taisho.co.jp
authors.forename: Shigeru
authors.initials: S
authors.lastname: Murakami
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kondo
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Toda
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kitajima
authors.forename: Kazuya
authors.initials: K
authors.lastname: Kameo
authors.forename: Masanobu
authors.initials: M
authors.lastname: Sakono
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Fukuda
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D002790:Cholesterol 7-alpha-Hydroxylase / Q000378:metabolism; D006224:Cricetinae; D004435:Eating / Q000187:drug effects; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008297:Male; D008647:Mesocricetus; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D011973:Receptors, LDL / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D002785:Sterol O-Acyltransferase / Q000378:metabolism; D013654:Taurine / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D013654:Taurine; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D002790:Cholesterol 7-alpha-Hydroxylase; D002785:Sterol O-Acyltransferase